Get started
Author

Damon L. Meyer

Effects of Drug Loading on the Antitumor Activity of a Monoclonal Antibody Drug Conjugate
2004 · Kevin J. Hamblett, Peter D. Senter, et al. · Clinical Cancer Research · 1,252
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
2003 · Svetlana O Doronina, Brian E Toki, et al. · Nature Biotechnology · 1,207
cAC10-vcMMAE, an anti-CD30–monomethyl auristatin E conjugate with potent and selective antitumor activity
2003 · Joseph A. Francisco, Charles G. Cerveny, et al. · Blood · 931
Enhanced Activity of Monomethylauristatin F through Monoclonal Antibody Delivery: Effects of Linker Technology on Efficacy and Toxicity
2005 · Svetlana O. Doronina, Brian A. Mendelsohn, et al. · Bioconjugate Chemistry · 515
Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates
2008 · Stephen C. Alley, Dennis R. Benjamin, et al. · Bioconjugate Chemistry · 480
Lysosomal Trafficking and Cysteine Protease Metabolism Confer Target-specific Cytotoxicity by Peptide-linked Anti-CD30-Auristatin Conjugates
2006 · May S. Kung Sutherland, Russell J. Sanderson, et al. · Journal of Biological Chemistry · 296
CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.
2006 · Kam Fai Tse, Michael Jeffers, et al. · Clinical Cancer Research · 183
A Human Antibody–Drug Conjugate Targeting EphA2 Inhibits Tumor GrowthIn vivo
2008 · Dowdy Jackson, John Gooya, et al. · Cancer Research · 150
PDF
Lymphocyte Activation Antigen CD70 Expressed by Renal Cell Carcinoma Is a Potential Therapeutic Target for Anti-CD70 Antibody-Drug Conjugates
2006 · Che-Leung Law, Kristine A. Gordon, et al. · Cancer Research · 150
A comparative evaluation of conventional and pretargeted radioimmunotherapy of CD20-expressing lymphoma xenografts
2001 · Oliver W. Press, Melissa Corcoran, et al. · Blood · 148
PDF
Efficient Elimination of B-Lineage Lymphomas by Anti-CD20–Auristatin Conjugates
2004 · Che-Leung Law, Charles G. Cerveny, et al. · Clinical Cancer Research · 116
Comparison of anti-CD20 and anti-CD45 antibodies for conventional and pretargeted radioimmunotherapy of B-cell lymphomas
2003 · John M. Pagel, Nathan Hedin, et al. · Blood · 101
Antibody targeting of B-cell maturation antigen on malignant plasma cells
2007 · Maureen C. Ryan, Michelle Hering, et al. · Molecular Cancer Therapeutics · 87
PDF
Dipeptide-based highly potent doxorubicin antibody conjugates
2005 · Scott C. Jeffrey, Minh T. Nguyen, et al. · Bioorganic & Medicinal Chemistry Letters · 81
Biochemistry of Dioxygen
1985 · Llyod L. Ingraham, Damon L. Meyer · Springer eBooks · 73
Reduced antibody response to streptavidin through site‐directed mutagenesis
2001 · Damon L. Meyer, Jody Schultz, et al. · Protein Science · 70
PDF
Comparison of immunoscintigraphy, efficacy, and toxicity of conventional and pretargeted radioimmunotherapy in CD20-expressing human lymphoma xenografts.
2003 · Krishnan Subbiah, Don K Hamlin, et al. · PubMed · 67
Site-specific prodrug activation by antibody-beta-lactamase conjugates: regression and long-term growth inhibition of human colon carcinoma xenograft models.
1993 · D L Meyer, L N Jungheim, et al. · PubMed · 62
Minor groove binder antibody conjugates employing a water soluble β-glucuronide linker
2007 · Scott C. Jeffrey, Minh T. Nguyen, et al. · Bioorganic & Medicinal Chemistry Letters · 59
A novel targeted delivery system utilizing a cephalosporin-oncolytic prodrug activated by an antibody β-lactamase conjugate for the treatment of cancer
1991 · Timothy A. Shepherd, Louis N. Jungheim, et al. · Bioorganic & Medicinal Chemistry Letters · 57
Catalases and Peroxidases
1985 · Llyod L. Ingraham, Damon L. Meyer · Springer eBooks · 55
Evaluation of RGD-Targeted Albumin Carriers for Specific Delivery of Auristatin E to Tumor Blood Vessels
2006 · Kai Temming, Damon L. Meyer, et al. · Bioconjugate Chemistry · 52
Improved Efficacy of αvβ3-Targeted Albumin Conjugates by Conjugation of a Novel Auristatin Derivative
2007 · Kai Temming, Damon L. Meyer, et al. · Molecular Pharmaceutics · 45
Vitamin E-Enhanced Humoral Antibody Response to Clostridium Perfringens Type D in Sheep
1983 · R.P. Tengerdy, D.L. Meyer, et al. · British Veterinary Journal · 45
Preparation and characterization of a .beta.-lactamase-Fab' conjugate for the site-specific activation of oncolytic agents
1992 · Damon L. Meyer, Louis N. Jungheim, et al. · Bioconjugate Chemistry · 39
Works count: 71
Citation count: 6,609
H-index: 29
I10-index: 34
Year
Topic
Type